Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal MicroenvironmentMary E. Vail, Martin Lackmann, Carmel Murone et al.|Cancer Research|2014Cited by 82
The eosinophil surface receptor epidermal growth factor–like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disordersFanny Legrand, Amy D. Klion, Varghese Palath et al.|Journal of Allergy and Clinical Immunology|2014Cited by 68
A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activityNenad Tomašević, Christopher Bebbington, Kenneth R. Luehrsen et al.|Growth Factors|2014Cited by 13
A Recombinant Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Against Various Hematologic Malignancies Shows Selective Inhibition of Colony Formation From Long-Term Culture-Initiating Cells (LTC-ICs) In Primary Leukemia SamplesVarghese Palath, Christopher Bebbington, Rohini Vekhande et al.|Blood|2010Cited by 6
A Recombinant Antibody to EphA3 for the Treatment of Hematologic Malignancies: Research Update and Interim Phase 1 Study ResultsA. Hagey, Jonathan A. Leff, Jeffrey E. Lancet et al.|Blood|2011Cited by 6